Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02811510Phase 1Recruiting
Phase 1, randomised, double-blind trial comparing THC with Placebo (2 arms). Primary endpoints: Change from Baseline: Rewarding Effects measured by Visual Analog Scale (VAS) at 300 months and Change from Baseline: Verbal Learning: Measured by Rey Auditory Verbal Learning Test (RAVLT) at 80 months. Started Jun 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02811510.